BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Janho Dit Hreich S, Benzaquen J, Hofman P, Vouret-Craviari V. To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question. Purinergic Signal 2021. [PMID: 34347213 DOI: 10.1007/s11302-021-09811-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 sheng G, Gao Y, Ding Q, Zhang R, Wang T, Jing S, Zhao H, Ma T, Wu H, Yang Y. P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization.. [DOI: 10.21203/rs.3.rs-2163991/v1] [Reference Citation Analysis]
2 Adamson MS, Nesic S, Buness A, Bayrak K, Schmitz S, Soler S, Zillinger T, Marx S, Lambing S, Andryka-cegielski K, Khan F, Schlee-guimarães TM, Herberhold S, Proietti M, Placek K, Reading P, Cicin-sain L, Schlee M, van den Boorn J, Hartmann E, Hartmann G, Bartok E. RIG-I activation primes and trains innate antiviral immune memory.. [DOI: 10.1101/2022.10.27.514004] [Reference Citation Analysis]
3 Ferrari D, Gessi S, Merighi S, Nigro M, Travagli A, Burns JS. Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling. Front Cell Dev Biol 2022;10:893709. [DOI: 10.3389/fcell.2022.893709] [Reference Citation Analysis]
4 Le Naour J, Sztupinszki Z, Carbonnier V, Casiraghi O, Marty V, Galluzzi L, Szallasi Z, Kroemer G, Vacchelli E. A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients. OncoImmunology 2022;11:2059878. [DOI: 10.1080/2162402x.2022.2059878] [Reference Citation Analysis]
5 Janho Dit Hreich S, Benzaquen J, Hofman P, Vouret-Craviari V. The Purinergic Landscape of Non-Small Cell Lung Cancer. Cancers (Basel) 2022;14:1926. [PMID: 35454832 DOI: 10.3390/cancers14081926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rao R, Shah S, Bhattacharya D, Toukam DK, Cáceres R, Pomeranz Krummel DA, Sengupta S. Ligand-Gated Ion Channels as Targets for Treatment and Management of Cancers. Front Physiol 2022;13:839437. [PMID: 35350689 DOI: 10.3389/fphys.2022.839437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]